A
ISSUER//CIK 0001628738
Audentes Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A67.4 KBAudentes Therapeutics, Inc.Feb 14, 4:25 PM ET·0001104659-20-021813
- SC 13G/A109.2 KBAudentes Therapeutics, Inc.Feb 14, 4:20 PM ET·0001172661-20-000840
- SC 13G/A153.9 KBAudentes Therapeutics, Inc.Feb 14, 4:05 PM ET·0001104659-20-021676
- SC 13G13.7 KBAudentes Therapeutics, Inc.Feb 11, 4:39 PM ET·0001104659-20-016339
- SC 13G/A13.4 KBAudentes Therapeutics, Inc.Feb 5, 11:25 AM ET·0000834237-20-004619
- 8-K311.6 KBAudentes Therapeutics, Inc.Jan 15, 10:03 AM ET·0001193125-20-007673
- SC 13G/A33.4 KBAudentes Therapeutics, Inc.Jan 7, 10:17 AM ET·0000902219-20-000003
- 8-K169.3 KBAudentes Therapeutics, Inc.Dec 16, 6:51 AM ET·0001193125-19-314351
- 8-K1.0 MBAudentes Therapeutics, Inc.Dec 2, 8:21 PM ET·0001193125-19-304554
- SC 13G/A8.4 KBAudentes Therapeutics, Inc.Nov 12, 12:11 PM ET·0000315066-19-001760
Insiders
10- 5AM VENTURES III, L.P.former 10% owner
- Conner Edward R.SVP, Chief Medical Officer
- DIEKMAN JOHN DFomer 10% owner
- Goldberg Mark AlanDirector
- GRAY JOHN T.SVP, Chief Scientific Officer
- Holles Natalie C.Senior Vice President, COO
- ISALY SAMUEL D10% Owner
- Jarrett JenniferDirector
- LANGE LOUIS GDirector
- Meltz Mark ASVP, General Counsel
Tickers
No tickers on record
Addresses
business
600 CALIFORNIA ST., 17TH FLOOR
SAN FRANCISCO, CA, 94108
mailing
600 CALIFORNIA ST., 17TH FLOOR
SAN FRANCISCO, CA, 94108